Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/9/2025

Treatment of Cellulitis in Adult Patients

Antibiotic Selection

  • The American College of Physicians recommends a 5-day course of antibiotics active against streptococci and Staphylococcus aureus as the first-line therapy for uncomplicated cellulitis in adults, with extension if the infection has not improved within this time period 1, 2
  • For typical cases without systemic signs of infection, antimicrobial agents active against streptococci, such as penicillin, amoxicillin, amoxicillin-clavulanate, dicloxacillin, cephalexin, or clindamycin are recommended 1
  • When MRSA is a concern, consider trimethoprim-sulfamethoxazole, clindamycin, or linezolid 3, 2
  • For diabetic patients with mild to moderate infections, broader coverage including both streptococci and S. aureus is recommended with options such as amoxicillin-clavulanate, trimethoprim-sulfamethoxazole, or clindamycin 2

Severe Cellulitis (Inpatient Treatment)

  • For patients with systemic signs of infection, intravenous antibiotics are recommended 3, 4
  • Initial empiric therapy should include vancomycin, linezolid, daptomycin, telavancin, or ceftaroline when MRSA risk factors are present 3
  • For severe cellulitis with skin sloughing or concern for necrotizing infection, broader coverage with vancomycin plus piperacillin-tazobactam or a carbapenem is recommended 4

Duration of Therapy

  • The recommended initial duration is 5 days, with extension if the infection has not improved within this time period 1, 2
  • For severe infections with skin sloughing, longer courses (10-14 days) may be necessary based on clinical response 4
  • Evaluation of response should occur every 2-5 days initially for outpatients 2

Adjunctive Measures

  • Elevation of the affected area to promote drainage of edema and inflammatory substances is recommended 1, 4
  • Identification and treatment of predisposing factors such as edema, obesity, eczema, venous insufficiency, and toe web abnormalities is recommended 3, 2
  • Systemic corticosteroids could be considered in non-diabetic adult patients to reduce inflammation 3, 1

Hospitalization Criteria

  • Severe infections with SIRS (systemic inflammatory response syndrome) require hospitalization 1, 4
  • Altered mental status or hemodynamic instability require hospitalization 4
  • Concern for deeper or necrotizing infection requires hospitalization 1, 4

Prevention of Recurrence

  • For patients with 3-4 episodes of cellulitis per year despite treatment of predisposing factors, prophylactic antibiotics should be considered 3, 1
  • Options include oral penicillin or erythromycin twice daily for 4-52 weeks, or intramuscular benzathine penicillin every 2-4 weeks 3, 2
  • This prophylactic program should continue as long as predisposing factors persist 3

Special Considerations

  • For surgical site infections, suture removal plus incision and drainage should be performed 3
  • Blood cultures should be obtained in patients with severe systemic features, malignancy, or unusual predisposing factors 4

REFERENCES

1

Treatment of Preseptal Cellulitis [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

2

Management of Cellulitis in Diabetic Patients [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

4

Treatment of Severe Cellulitis with Skin Sloughing [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025